Phase I study of ARN-810, a novel and potent oral selective estrogen receptor degrader, in postmenopausal women with metastatic estrogen receptor positive (ER+), HER2-breast cancer Meeting Abstract
| Authors: | Bardia, A.; Dickler, M. N.; Mayer, I. A.; Winer, E. P.; Mahmood, U.; Ulaner, G.; Manning, H. C.; Rix, P.; Hager, J. H.; Roychowdhury, D.; Maneval, E. C.; Arteaga, C. L.; Baselga, J. |
| Abstract Title: | Phase I study of ARN-810, a novel and potent oral selective estrogen receptor degrader, in postmenopausal women with metastatic estrogen receptor positive (ER+), HER2-breast cancer |
| Meeting Title: | 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 75 |
| Issue: | 9 Suppl. |
| Meeting Dates: | 2014 Dec 9-13 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2015-05-01 |
| Language: | English |
| ACCESSION: | WOS:000356730201024 |
| DOI: | 10.1158/1538-7445.sabcs14-p1-13-01 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P1-13-01 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work